Search results
Results from the WOW.Com Content Network
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, [3] headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology.
Zymergen was founded in 2013. [5] by investment banker Joshua Hoffman, biophysicist Zach Serber, and biochemist Jed Dean. [6]All three met while working at Amyris, Inc. [7] The company uses machine learning and artificial intelligence to study and modify microbes which ferment carbon [6] to produce chemicals used in manufacturing consumer goods and pharmaceuticals. [8]
Venter (and Smith)'s previous company, Celera Genomics, was a driving force in the race to sequence the human genome. [9] The firm takes its name from the phrase synthetic genomics which is a scientific discipline of synthetic biology related to the generation of organisms artificially using genetic material. [10] [11]
The company provides an extensive range of products for the synthetic biology industry, such as CRISPR & Gene editing tools. To meet the growing demand for biopharmaceuticals and biotechnological resources, Merck undertakes investments in biomanufacturing technologies that boost the capacity and productivity of biological production processes.
The field of synthetic biology has not been good to investors. But maybe we've just been looking in the wrong places. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 ...
How to Prepare Your Business for Synthetic Biology [14] [15] Cumbers has written on aging and insulin signalling, [16] the characterization of biological parts, [17] resource utilization on space missions, [18] synthetic biology in space, [19] [20] extremophiles (cyanobacteria and tardigrades) [21] and the impact of space resources on financial ...
The company develops genetic engineering and reproductive technology for conservation biology. It was founded in 2021 by George Church and Ben Lamm, [3] and is based in Dallas, Texas. [10] [11] As of 2025, Colossal is the highest valued company based in Dallas, Texas at $10.2 billion. [12] [13]
Sphere Fluidics is a Cambridge(UK)-based Life Sciences R&D company that specializes in biopharmaceutical discovery and development, cell therapy engineering, bioproduction and synthetic biology, analysis and isolation. The company is reported to own 25 patented products that include instruments, biochips, and specialist chemicals. [2] [3]